知镜 Cognispect · 医学文献与研究工作台

Lipid metabolism and pulmonary arterial hypertension.

Sun Y, Gao P, Lv C, Li M, Zhang Y, Liu M, Zhu L.
Cellular signalling · 2026-10-22 · PMID 42913899

文献摘要

Pulmonary arterial hypertension (PAH) is a rare and progressive disease characterized by pulmonary vascular remodeling and progressive narrowing of the pulmonary arteries. Recent studies have shown that changes in lipid metabolism and lipid action play an important role in the pathogenesis of PAH, involving membrane integrity, energy metabolism, inflammatory response, and pulmonary vascular remodeling. Lipoprotein receptor deficiency further exacerbates inflammation, fibrosis, and associated pathological processes in PAH. This review summarizes the role of many lipid-active substances and their signaling pathways in the pathogenesis of PAH, sorting the biomarkers related to the severity and prognosis of PAH and discussing the potential application of drug therapy targeting lipid metabolism in managing PAH. This review aims to identify clinically relevant lipid molecules and candidate biomarkers, and to provide new insights and potential targets for precision oriented diagnosis and treatment of PAH.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。